14-BROMODAUNORUBICIN HYDROBROMIDE
UNII H9SSG355HK

Substance Identification & Data

This profile provides standardized clinical and technical data for 14-bromodaunorubicin Hydrobromide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) H9SSG355HK.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 60873-68-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
H9SSG355HK
CAS Registry Number
60873-68-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
14-BROMODAUNORUBICIN HYDROBROMIDE
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C27H28BrNO10.BrH
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
MYLSQMUXMDHPTM-RUELKSSGSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
12822071
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
Oc1c2c([C@@H](O[C@]3(C[C@H](N)[C@H](O)[C@H](C)O3)[H])C[C@@](C(CBr)=O)(O)C2)c(O)c4c1C(=O)c5c(C4=O)c(OC)ccc5.Br

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 14-bromodaunorubicin Hydrobromide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

14-BROMODAUNOMYCIN HYDROBROMIDE
14-BROMODAUNORUBICIN HYDROBROMIDE

Systematic Nomenclature

(8S,10S)-10-(((2R,4S,5S,6S)-4-AMINO-5-HYDROXY-6-METHYLOXAN-2-YL)OXY)-8-(2-BROMOACETYL)-6,8,11-TRIHYDROXY-1-METHOXY-5,7,8,9,10,12-HEXAHYDROTETRACENE-5,12-DIONE HYDROBROMIDE
5,12-NAPHTHACENEDIONE, 10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-8-(2-BROMOACETYL)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-1-METHOXY-, HYDROBROMIDE (1:1), (8S,10S)-
5,12-NAPHTHACENEDIONE, 10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-8-(BROMOACETYL)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-1-METHOXY-, HYDROBROMIDE, (8S,10S)-
5,12-NAPHTHACENEDIONE, 10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-8-(BROMOACETYL)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-1-METHOXY-, HYDROBROMIDE, (8S-CIS)-

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NLM
PubChem Compound